ResearcherGerman Cancer Research CenterActive in the last 2 years
Mohamed Saiel Saeed Alhamdani
Matched on ORCID iD 0000-0001-9168-3895; OpenAlex author ID A5042879618. Sources: OpenAlex.
Their work
- Papers
- 7 (first author 2, last author 1)
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 34
2012: 1 paper · 2013: none · 2014: none · 2015: none · 2016: none · 2017: 1 paper · 2018: none · 2019: none · 2020: 1 paper · 2021: 1 paper · 2022: none · 2023: none · 2024: none · 2025: 1 paper · 2026: 2 papers
Papers 7
- ATM Deficiency Induces TGFβ-Mediated Stromal Programming in Pancreatic Cancer. Co-author DOI 10.1158/0008-5472.can-26-0138↗
- Blood-based prediction and early detection of pancreatic cancer recurrence after tumor resection Co-author DOI 10.20892/j.issn.2095-3941.2025.0495↗
- Phoenix dactylifera L. (date palm) fruit extracts and fractions exhibit anti-proliferative activity against human pancreatic cancer cell lines. Co-author DOI 10.1016/j.heliyon.2025.e42274↗
- Blood biomarkers for differential diagnosis and early detection of pancreatic cancer. First author DOI 10.1016/j.ctrv.2021.102193↗
- Antifibrotic and tumor microenvironment modulating effect of date palm fruit (Phoenix dactylifera L.) extracts in pancreatic cancer. First author DOI 10.1016/j.biopha.2019.109522↗
- Comparison of the tumor cell secretome and patient sera for an accurate serum-based diagnosis of pancreatic ductal adenocarcinoma. Last author DOI 10.18632/oncotarget.14449↗
- Immunoassay-based proteome profiling of 24 pancreatic cancer cell lines. Co-author DOI 10.1016/j.jprot.2012.04.042↗
Closest collaborators
The 25 strongest of 34 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Jörg D. Hoheisel · 7 shared papers, 2012–2026 · strength 1.19
- Paper Phoenix dactylifera L. (date palm) fruit extracts and fractions exhibit anti-proliferative activity against human pancr… DOI 10.1016/j.heliyon.2025.e42274↗
- Paper Blood-based prediction and early detection of pancreatic cancer recurrence after tumor resection DOI 10.20892/j.issn.2095-3941.2025.0495↗
- Paper ATM Deficiency Induces TGFβ-Mediated Stromal Programming in Pancreatic Cancer. DOI 10.1158/0008-5472.can-26-0138↗
- Younis Baqi · 2 shared papers, 2020–2025 · strength 0.53
- Paper Phoenix dactylifera L. (date palm) fruit extracts and fractions exhibit anti-proliferative activity against human pancr… DOI 10.1016/j.heliyon.2025.e42274↗
- Paper Antifibrotic and tumor microenvironment modulating effect of date palm fruit (Phoenix dactylifera L.) extracts in pancr… DOI 10.1016/j.biopha.2019.109522↗
- Reem A. Al Alawi · 2 shared papers, 2020–2025 · strength 0.53
- Paper Phoenix dactylifera L. (date palm) fruit extracts and fractions exhibit anti-proliferative activity against human pancr… DOI 10.1016/j.heliyon.2025.e42274↗
- Paper Antifibrotic and tumor microenvironment modulating effect of date palm fruit (Phoenix dactylifera L.) extracts in pancr… DOI 10.1016/j.biopha.2019.109522↗
- Markus Wolfgang Büchler · 3 shared papers, 2017–2026 · strength 0.45
- Paper Blood-based prediction and early detection of pancreatic cancer recurrence after tumor resection DOI 10.20892/j.issn.2095-3941.2025.0495↗
- Paper Blood biomarkers for differential diagnosis and early detection of pancreatic cancer. DOI 10.1016/j.ctrv.2021.102193↗
- Paper Comparison of the tumor cell secretome and patient sera for an accurate serum-based diagnosis of pancreatic ductal aden… DOI 10.18632/oncotarget.14449↗
- Thilo Hackert · 3 shared papers, 2017–2026 · strength 0.45
- Paper Blood-based prediction and early detection of pancreatic cancer recurrence after tumor resection DOI 10.20892/j.issn.2095-3941.2025.0495↗
- Paper Blood biomarkers for differential diagnosis and early detection of pancreatic cancer. DOI 10.1016/j.ctrv.2021.102193↗
- Paper Comparison of the tumor cell secretome and patient sera for an accurate serum-based diagnosis of pancreatic ductal aden… DOI 10.18632/oncotarget.14449↗
- Andrea S. Bauer · 3 shared papers, 2012–2026 · strength 0.43
- Paper Blood-based prediction and early detection of pancreatic cancer recurrence after tumor resection DOI 10.20892/j.issn.2095-3941.2025.0495↗
- Paper Blood biomarkers for differential diagnosis and early detection of pancreatic cancer. DOI 10.1016/j.ctrv.2021.102193↗
- Paper Immunoassay-based proteome profiling of 24 pancreatic cancer cell lines. DOI 10.1016/j.jprot.2012.04.042↗
- Fawaz N. Al-Shaheri · 2 shared papers, 2021–2026 · strength 0.40
- Miriam Schenk · 1 shared paper, 2026 · strength 0.25
- Ulrike Heger · 1 shared paper, 2026 · strength 0.25
- Nathalia A. Giese · 2 shared papers, 2017–2021 · strength 0.20
- Christopher J. Halbrook · 1 shared paper, 2026 · strength 0.18
- Austin D. Silva · 1 shared paper, 2026 · strength 0.18
- Élodie Roger · 1 shared paper, 2026 · strength 0.18
- Konrad Steinestel · 1 shared paper, 2026 · strength 0.18
- Rima Singh · 1 shared paper, 2026 · strength 0.18
- Michael Karl Melzer · 1 shared paper, 2026 · strength 0.18
- Frank Arnold · 1 shared paper, 2026 · strength 0.18
- Patrick Christian Hermann · 1 shared paper, 2026 · strength 0.18
- Johann Gout · 1 shared paper, 2026 · strength 0.18
- Alica K. Michels · 1 shared paper, 2026 · strength 0.18
- Dharini Srinivasan · 1 shared paper, 2026 · strength 0.18
- Roland Rad · 1 shared paper, 2026 · strength 0.18
- Alexander Kleger · 1 shared paper, 2026 · strength 0.18
- Thomas Theodor Werner Seufferlein · 1 shared paper, 2026 · strength 0.18
- Matthias J. Löhr · 1 shared paper, 2026 · strength 0.18
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.